| Bioactivity | Triacetylresveratrol, an acetylated analog of Resveratrol. Triacetylresveratrol decreases the phosphorylation of STAT3 and NF-κB in a dose- and time- dependent manner in PANC-1 and BxPC-3 cells. Anticancer effects[1]. | ||||||||||||
| Invitro | Triacetylresveratrol significantly down-regulates anti-apoptotic Bcl-2 family protein Mcl-1 and up-regulates pro-apoptotic Bcl-2 family proteins Bim and Puma. Triacetylresveratrol inhibits cell viability, and induces apoptosis of pancreatic cancer cells in a concentration and incubation time-dependent manner[1]. | ||||||||||||
| Name | Triacetylresveratrol | ||||||||||||
| CAS | 42206-94-0 | ||||||||||||
| Formula | C20H18O6 | ||||||||||||
| Molar Mass | 354.35 | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
Triacetylresveratrol
CAS: 42206-94-0 F: C20H18O6 W: 354.35
Triacetylresveratrol, an acetylated analog of Resveratrol. Triacetylresveratrol decreases the phosphorylation of STAT3 a
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.